NCT00146549View on ClinicalTrials.gov

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2007

Study Completion Date

December 31, 2007

Conditions
Breast CancerStage IV Breast Cancer
Interventions
DRUG

Trastuzumab

DRUG

Vinorelbine

DRUG

Paclitaxel

DRUG

Docetaxel

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

North Shore Medical Center

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER